In tribute to Lucy Romo – daughter of Bristan Group Sales Manager for Ireland Dennis Romo – who tragically lost her battle with Leukaemia last year, the company has announced that Leukaemia Research will be its charity partner for 2007.

 

First up on an impressive agenda of events that will see the Bristan Group joining forces in a bid to raise as much money as possible for Leukaemia Research is the gruelling London Triathlon. In a bid to inspire staff to get involved, Bristan Group CEO Steve Lee and Bristan MD Roger Williams are leading from the top and were amongst the first to sign up to this two day event, which takes part on the 4^th-5^th August 2007. Along with fellow team mates from across the Bristan Group, Steve Lee and Roger Williams recently began a punishing training schedule including swimming, cycling and running that will hopefully see them ‘match-fit’ before the big event.  On the big day the dedicated team will take part in a 1500m swim, followed by a 40km bike ride and topped off with a 10km run!

 

Steve Lee, CEO for the Bristan Group comments: “Leukaemia Research is a fantastic charity which ploughs an impressive 90p in every £1 into its research and we are delighted to get behind them.  It is a cause that is close to our hearts following the tragic death of Lucy Romo and we are passionate about raising as much money as possible to help research into this awful disease.”

Regarding the training programme for the London Triathlon itself he adds: “None of us are professional athletes so the training will no doubt be pretty gruelling, but we are prepared to quite literally put our blood, sweat and tears into getting fit and raising as much sponsorship as possible.  But this is just one in a whole programme of events that as a company we are organising and I have no doubt that all the staff will do their bit to make a real difference to this charity.”

Leukaemia Research was established in 1960 and is still the only national research charity devoted exclusively to leukaemia, the lymphomas, myeloma, aplastic anaemia, myelodysplasia, the myeloproliferative disorders and the related blood disorders in both children and adults. It receives no government grants and is dependant entirely on the support of voluntary donation from individuals and companies such as the Bristan Group to help it continue its invaluable work.